Faculty profile

Mark Clemons

ResearcherClinical EpidemiologyUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Mark Clemons

Researcher

Clinical Epidemiology

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
39 publications in the last five years, latest in 2026.
Senior (last) author on 14 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2011.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

177

Publications

731

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Breast Cancer Network Meta-Analysis Systematic Review Endocrine Therapy Older Patients Optimization Pragmatic Randomized Controlled Trial

Latest papers

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.
2026 · first author
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study
Journal of Medical Internet Research · 2026
Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy
Breast Cancer Research and Treatment · 2026 · senior author

All 177 publications

Latest funding

A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).
CIHR · 2025 · Principal investigator
$600,000
Knowledge Syntheses to Identify Best Treatments for Cancer Related Neurocognitive Dysfunction in Cancer Survivors
CIHR · 2022 · Principal investigator
$99,450
Decentralized, Remotely-Managed Pragmatic Clinical Trials Using The Rethinking Clinical Trials Platform (REaCT) and National Surgical Quality Improvement Program (NSQIP) to Improve Perioperative Care (REaCT-NSQIP-Remote)
SSHRC · 2021 · Co-investigator
$237,970

All 7 grants and awards

From the 150 most recent of 177 publications.

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Clemons M, Stober C, Pond GR, Conter H, Simos D, Dhesy-Thind S, Mates M, Trinkaus M, Hilton J, Savard M-F

20261 citationsFirst author

DOI: 10.1056/evidoa2500202

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

Pilgram L, Yang K, Beltran-Bless A-A, Pond GR, Vandermeer L, Hilton J, Savard M-F, LeBlanc A, Shepherd L, Chen B

Journal of Medical Internet Research20261 citations

DOI: 10.2196/88665

Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy

Leblanc A, Beltran-Bless A-A, Pond GR, El Emam K, Juwara L, Clemons L, Bayani J, Pilgram L, Pharoah P, Mallon E

Breast Cancer Research and Treatment20261 citationsSenior author

DOI: 10.1007/s10549-026-07909-5

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes

Beltran-Bless A-A, Himmelman E, Kim A, Pond GR, Fallah P, Ng T, Hilton J, Savard M-F, Larocque G, Baines K-A

Current Oncology2026Senior author

DOI: 10.3390/curroncol33040224

Comparative Effectiveness of Interventions to Treat Cancer Treatment-Related Cognitive Impairment in Adult Cancer Survivors Following Systemic Therapy: A Systematic Review with Network Meta-Analyses.

Wolfe DM, Hamel C, Berard J, Veroniki AA, Skidmore B, Kanji S, Rabheru K, McGee SF, Forbes L, de Lima Machado I, Liu M, Saunders D, Vandermeer L, Clemons M, Hutton B

Cancers2025

DOI: 10.3390/cancers17213430 PMID: 41228226

Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer.

Joy AA, Cheng N, Gelmon KA, Mates M, Desbiens C, Clemons M, Taylor S, Lemieux J, DeLuca A, Gasparini L, Lungu I, Soave D, Fortuna A, Pugh T, Liu SS, Bartlett JMS, Awadalla P, Spears M, Chen BE, Bayani J, Parulekar WR

Cancer research communications2025

DOI: 10.1158/2767-9764.crc-25-0346 PMID: 41123599

REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer.

Ng TL, Greenstreet P, Stober C, Nicholls S, Shamess J, Mills N, Ibrahim M, Savard MF, Rushton M, Awan A, Sehdev S, Hilton J, Song X, Fallah P, Alqahtani N, Davoudpour D, Daigle K, MacDonald F, Vandermeer L, Taljaard M, Clemons M

JNCI cancer spectrum2025Senior author

DOI: 10.1093/jncics/pkaf081 PMID: 40811630

The Rethinking Clinical Trials (REaCT) Program: A Pragmatic Research Strategy to Improve Cancer Care for Patients, Caregivers, and Healthcare Systems.

Savard MF, Clemons M, McGee SF

Current oncology (Toronto, Ont.)2025

DOI: 10.3390/curroncol32090484 PMID: 41002554

Putting Patients First: Pragmatic Trials in Gynecologic Oncology.

Hopkins L, Clemons M, Bemister K, Booth C, Kadar S, Karanicolas P, Mulligan J, Savard MF, Tannock I, Tone A, MacKay H

Current oncology (Toronto, Ont.)2025

DOI: 10.3390/curroncol32030139 PMID: 40136343

Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers

Beltran-Bless A-A, Larocque G, Arnaout A, Caudrelier J-M, Hilton J, Alqahtani N, Vandermeer L, Pond G, Clemons M

Supportive Care in Cancer2025Senior author

DOI: 10.1007/s00520-025-09205-2

A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).

Principal investigatorCIHR2025Project Grant

Principal investigators: Savard, Marie-France; Clemons, Mark J; Pond, Gregory R

Keywords: Breast Cancer; Endocrine Therapy; Older Patients; Optimization; Pragmatic; Randomized Controlled Trial

$600,000

Knowledge Syntheses to Identify Best Treatments for Cancer Related Neurocognitive Dysfunction in Cancer Survivors

Principal investigatorCIHR2022Project Grant

Principal investigators: Hutton, Brian E; Arnaout, Angel; Clemons, Mark J

Keywords: Cancer; Cancer Survivorship; Chemotherapy; Cognitive Functioning; Knowledge Synthesis; Meta-Analysis; Network Meta-Analysis; Neurocognitive Dysfunction; Systematic Review

$99,450

Decentralized, Remotely-Managed Pragmatic Clinical Trials Using The Rethinking Clinical Trials Platform (REaCT) and National Surgical Quality Improvement Program (NSQIP) to Improve Perioperative Care (REaCT-NSQIP-Remote)

Co-investigatorSSHRC2021New Frontiers in Research Fund - Special Call

Principal investigators: Auer, Rebecca

Keywords: Remotely managed pragmatic clinical trials automatic data collection for randomised trials Rethinking Clinical Trials Surgical quality improvement Decentralized clinical trials Surgical wound infections Rural and community populations Pragmatic clinical trials Postoperative complications Research Design

$237,970

Systematic review of non-hormonal interventions for management of hot flashes in breast cancer and prostate cancer

Nominated PICIHR2014Knowledge Synthesis Grant

Principal investigators: Clemons, Mark J; Hutton, Brian E

Keywords: Breast Cancer; Evidence Synthesis; Hot Flashes; Network Meta-Analysis; Protate Cancer; Systematic Review; Vasomotor Symptom

$100,000

Bone and Oncology New Updates meeting 2014 (BONUS 9 Symposium)

Nominated PICIHR2013Dissemination Events - Priority Announcement: Cancer Research

Principal investigators: Clemons, Mark J

Keywords: Bone Metastases And Oncology; Knowledge Translation; Multi-Disciplinary Symposium; Translational Research

$25,000

Adding clarity to uncertainty in the study of drug safety

Co-investigatorCIHR2012Operating Grant - PA: Drug Safety and Effectiveness (bridge funding)

Principal investigators: Hutton, Brian E

Keywords: Drug Safety; Meta-Analysis; Network Meta-Analysis

$100,000

A phase 2 clinical trial exploring the clinical and correlative effects of combining doxycycline with standard bisphosphonate therapy in patients with metastatic breast cancer. (The Achilles study).

SupervisorCIHR2011Fellowship - PA: CIHR/Rx&D - CAMO Research Program

Principal investigators: Simos, Demetrios

Keywords: Bone Metastases; Breast Cancer; Clinical Trials

$55,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Mark Clemons

Research

Latest papers

Latest funding

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes

Comparative Effectiveness of Interventions to Treat Cancer Treatment-Related Cognitive Impairment in Adult Cancer Survivors Following Systemic Therapy: A Systematic Review with Network Meta-Analyses.

Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer.

REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer.

The Rethinking Clinical Trials (REaCT) Program: A Pragmatic Research Strategy to Improve Cancer Care for Patients, Caregivers, and Healthcare Systems.

Putting Patients First: Pragmatic Trials in Gynecologic Oncology.

Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers

A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).

Knowledge Syntheses to Identify Best Treatments for Cancer Related Neurocognitive Dysfunction in Cancer Survivors

Decentralized, Remotely-Managed Pragmatic Clinical Trials Using The Rethinking Clinical Trials Platform (REaCT) and National Surgical Quality Improvement Program (NSQIP) to Improve Perioperative Care (REaCT-NSQIP-Remote)

Systematic review of non-hormonal interventions for management of hot flashes in breast cancer and prostate cancer

Bone and Oncology New Updates meeting 2014 (BONUS 9 Symposium)

Adding clarity to uncertainty in the study of drug safety

A phase 2 clinical trial exploring the clinical and correlative effects of combining doxycycline with standard bisphosphonate therapy in patients with metastatic breast cancer. (The Achilles study).

Frequent collaborators

Brian Hutton

Gregory Pond

John Hilton

Dean Fergusson

Angel Arnaout

Marie-France Savard

Eitan Amir

Sharon McGee

Christina Addison

Jean-Michel Caudrelier

Stephanie Smith

Kednapa Thavorn

Andrew Robinson

Kednapa Thavorn

Michael Ong

Paul Wheatley-Price

Khaled El Emam

Muriel Brackstone

Sukhbinder Dhesy-Thind

Gurmit Singh

Salmaan Kanji

Melanie Spears

Ophira Ginsburg

Christopher Booth

Gregory Pond

Norman Buckley

Andreas Laupacis

Laurent Azoulay

David Moher

Monica Taljaard

Andrea Eisen

Andrea Tricco

Gerald Batist

Gerald Batist

ATILLA Omeroglu

Paul Karanicolas

Stuart Nicholls

Sambasivarao Damaraju

Louise Bordeleau

Svetlana Komarova